# Hypertension Management in Cancer Patients

> **NCT03919214** · NA · TERMINATED · sponsor: **Duke University** · enrollment: 4 (actual)

## Conditions studied

- Blood Pressure
- Hypertension
- Cancer
- Cancer, Breast
- Cancer of Prostate
- CLL
- Hematopoietic Malignancy

## Interventions

- **OTHER:** Automated Messaging

## Key facts

- **NCT ID:** NCT03919214
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-10
- **Primary completion:** 2020-06-03
- **Final completion:** 2020-06-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Initially suspended due to Covid-19. After much consideration, it was determined that we do not have the bandwidth to resume recruitment or any activities for this project.
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919214, "Hypertension Management in Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03919214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*